Home › Funds › AXIOM INVESTORS LLC /DE › JNJ

AXIOM INVESTORS LLC /DE position in JNJ

JOHNSON & JOHNSON · Health Care

AXIOM INVESTORS LLC /DE reported holding 660,027 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$174.7M, representing 1.25% of its reported portfolio and ranking #19 among its reported holdings. AXIOM INVESTORS LLC /DE has disclosed JNJ holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)660.03K sh
Reported value held$174.74M
Portfolio Weight1.25%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AXIOM INVESTORS LLC /DE's JNJ position evolved

AXIOM INVESTORS LLC /DE first disclosed a stake in JNJ in Q2 2026 at 491,072 shares (US$124.7M). The position peaked in Q3 2026 at 660,027 shares, worth US$174.7M. Across 2 filings, AXIOM INVESTORS LLC /DE increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 660,027 shares valued at US$174.7M — an increase of 168,955 shares quarter over quarter.. Notable position changes include a 34% increase in Q3 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 491.07K $124.72M New
Q3 2026 660.03K $174.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has AXIOM INVESTORS LLC /DE held JNJ?

AXIOM INVESTORS LLC /DE has disclosed JNJ holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is AXIOM INVESTORS LLC /DE's current position in JNJ?

As of Q3 2026, AXIOM INVESTORS LLC /DE holds 660.03K shares of JNJ (JOHNSON & JOHNSON), valued at $174.74M, representing 1.25% of its reported portfolio and ranking #19.

Has AXIOM INVESTORS LLC /DE been buying or selling JNJ?

In the latest 13F filing (Q3 2026), AXIOM INVESTORS LLC /DE increased its position in JNJ. The position peaked in Q3 2026 at 660.03K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.